Compounds > carvedilol

carvedilol and rivaroxaban

carvedilol has been researched along with rivaroxaban in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Akçay, M; Aslan, AN; Baştuğ, S; Bozkurt, E; Durmaz, T; Sari, C; Sari, SÖ1

Other Studies

2 other study(ies) available for carvedilol and rivaroxaban

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Severe jaundice due to intrahepatic cholestasis after initiating anticoagulation with rivaroxaban.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2016, Volume: 27, Issue:2

    Topics: Aged; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Cholestasis, Intrahepatic; Humans; Hypertension; Jaundice; Liver; Male; Perindopril; Propanolamines; Rivaroxaban; Severity of Illness Index; Treatment Outcome

2016